{"id":"ramipril-ace-inhibitor","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Dry cough"},{"rate":"5-10","effect":"Dizziness"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-5","effect":"Hyperkalemia"},{"rate":"0.1-0.5","effect":"Angioedema"},{"rate":"2-4","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ACE inhibitors block the enzyme responsible for producing angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, ramipril causes vasodilation, decreases peripheral vascular resistance, and reduces aldosterone secretion, leading to lower blood pressure and improved cardiac function. This mechanism also provides cardioprotective and renoprotective effects.","oneSentence":"Ramipril inhibits angiotensin-converting enzyme (ACE), reducing the conversion of angiotensin I to angiotensin II and thereby lowering blood pressure and reducing cardiac workload.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:03:50.819Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure"},{"name":"Post-myocardial infarction"},{"name":"Diabetic nephropathy prevention"}]},"trialDetails":[{"nctId":"NCT07099677","phase":"NA","title":"Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk","status":"RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2025-08-01","conditions":"Hypertension, Fall Risk, Postural Balance","enrollment":186},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT07315139","phase":"NA","title":"Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-02-01","conditions":"Pentoxifylline, Inflammatory Markers, Non-Diabetic","enrollment":42},{"nctId":"NCT01037530","phase":"PHASE4","title":"Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants","status":"COMPLETED","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2010-12","conditions":"Intermittent Claudicants","enrollment":33},{"nctId":"NCT07259512","phase":"PHASE4","title":"Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure","status":"RECRUITING","sponsor":"Evi Liliek Wulandari","startDate":"2025-06-30","conditions":"Chronic Kidney Disease, Heart Failure With Reduced Ejection Fraction (HFrEF)","enrollment":80},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT04983823","phase":"NA","title":"Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)","status":"RECRUITING","sponsor":"Baker Heart and Diabetes Institute","startDate":"2021-11-18","conditions":"Heart Failure","enrollment":820},{"nctId":"NCT07184918","phase":"NA","title":"Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-02-01","conditions":"Contrast-Induced Nephropathy, Coronary Angiography, Acute Kidney Injury","enrollment":44},{"nctId":"NCT06562582","phase":"PHASE4","title":"STunning in Acute Myocardial Infarction - BAS","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2025-01-06","conditions":"Myocardial Infarct","enrollment":120},{"nctId":"NCT05942053","phase":"PHASE4","title":"Role of Vitamin K2 in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-07-15","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT07023016","phase":"PHASE2, PHASE3","title":"Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure","status":"COMPLETED","sponsor":"National Heart Institute, Egypt","startDate":"2023-11-01","conditions":"Acute Decompensated Heart Failure (ADHF), Chronic Kidney Disease (CKD)","enrollment":515},{"nctId":"NCT05942027","phase":"PHASE4","title":"Role of Coenzyme Q10 in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-07-15","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT04962711","phase":"NA","title":"Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)","status":"RECRUITING","sponsor":"Baker Heart and Diabetes Institute","startDate":"2023-03-30","conditions":"Heart Failure","enrollment":685},{"nctId":"NCT05637853","phase":"PHASE4","title":"Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2022-10-22","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT02901977","phase":"PHASE4","title":"Doxazosin and Ramipril in Hypertension","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2011-03","conditions":"Hypertension","enrollment":71},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT00933231","phase":"PHASE3","title":"Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-08-17","conditions":"Kidney Transplantation","enrollment":281},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT02008786","phase":"PHASE4","title":"Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD","status":"TERMINATED","sponsor":"Cardiology Research UBC","startDate":"2014-06","conditions":"Coronary Artery Dissection, Spontaneous","enrollment":18},{"nctId":"NCT06304896","phase":"PHASE1","title":"Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Arab Contractors Medical Centre","startDate":"2024-05-01","conditions":"Chemotherapy Induced Systolic Dysfunction","enrollment":150},{"nctId":"NCT06187493","phase":"NA","title":"Treatment of Patients With Diabetic Kidney Disease","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Diabetic Kidney Disease","enrollment":70},{"nctId":"NCT01669434","phase":"PHASE4","title":"Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2015-06-01","conditions":"Hypotension on Induction","enrollment":291},{"nctId":"NCT02924727","phase":"PHASE3","title":"Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2016-12-09","conditions":"Acute Myocardial Infarction","enrollment":5669},{"nctId":"NCT05271448","phase":"NA","title":"Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-06-01","conditions":"Contrast-induced Nephropathy, Chronic Kidney Diseases, Ischemic Heart Disease","enrollment":600},{"nctId":"NCT03011775","phase":"PHASE4","title":"Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease","status":"COMPLETED","sponsor":"Ukrainian Medical Stomatological Academy","startDate":"2012-11","conditions":"Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance Syndrome","enrollment":43},{"nctId":"NCT02130687","phase":"NA","title":"Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2014-06","conditions":"Type 2 Diabetes Mellitus, Hypertension","enrollment":106},{"nctId":"NCT02721342","phase":"","title":"Remission Clinic in Proteinuric Chronic Nephropathies","status":"UNKNOWN","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2009-06","conditions":"Chronic Kidney Disease","enrollment":1500},{"nctId":"NCT02236806","phase":"PHASE3","title":"Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2015-07","conditions":"Breast Cancer, Cardiotoxicity","enrollment":262},{"nctId":"NCT05133050","phase":"NA","title":"Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants","status":"NOT_YET_RECRUITING","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2022-01-01","conditions":"Alport Syndrome","enrollment":510},{"nctId":"NCT03201185","phase":"PHASE4","title":"Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)","status":"UNKNOWN","sponsor":"Hospital Clínico Universitario de Valladolid","startDate":"2018-02-10","conditions":"Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors","enrollment":194},{"nctId":"NCT04320589","phase":"PHASE2","title":"the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2019-06-30","conditions":"Pheochromocytoma","enrollment":30},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT02086019","phase":"NA","title":"Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes","status":"COMPLETED","sponsor":"Brighton and Sussex University Hospitals NHS Trust","startDate":"2014-05-01","conditions":"Acute Coronary Syndromes","enrollment":250},{"nctId":"NCT00985322","phase":"PHASE3","title":"Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2009-05","conditions":"Left Ventricular Hypertrophy, Hypertension","enrollment":269},{"nctId":"NCT04582097","phase":"PHASE2, PHASE3","title":"Ramipril in Pediatric Patients on Hemodialysis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-12-01","conditions":"Hemodialysis","enrollment":135},{"nctId":"NCT02632747","phase":"PHASE2","title":"Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-05-10","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Obesity","enrollment":31},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT04364139","phase":"PHASE3","title":"African American Study of Kidney Disease and Hypertension","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1995-02-01","conditions":"Hypertensive Nephrosclerosis, Chronic Renal Insufficiency","enrollment":1094},{"nctId":"NCT04143412","phase":"PHASE2","title":"Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2019-02-04","conditions":"Diabetic Nephropathy Type 2, Microalbuminuria Due to Type 2 Diabetes Mellitus","enrollment":75},{"nctId":"NCT00512759","phase":"PHASE4","title":"Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2007-12-10","conditions":"Acute Heart Failure","enrollment":781},{"nctId":"NCT02200822","phase":"PHASE4","title":"Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients","status":"COMPLETED","sponsor":"Hasselt University","startDate":"2014-07","conditions":"Heart Failure (HF)","enrollment":80},{"nctId":"NCT03979976","phase":"PHASE2, PHASE3","title":"Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2011-03","conditions":"Systemic Lupus Erythematosus","enrollment":37},{"nctId":"NCT02832973","phase":"PHASE4","title":"Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension","status":"COMPLETED","sponsor":"Sao Jose do Rio Preto Medical School","startDate":"2015-09","conditions":"Hypertension Resistant to Conventional Therapy","enrollment":72},{"nctId":"NCT01234922","phase":"PHASE2","title":"Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-02","conditions":"Hypertension, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":6},{"nctId":"NCT01867047","phase":"NA","title":"ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients","status":"TERMINATED","sponsor":"Duke University","startDate":"2013-06","conditions":"Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension","enrollment":59},{"nctId":"NCT01715584","phase":"PHASE4","title":"Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-07","conditions":"Hypertension","enrollment":80},{"nctId":"NCT01856361","phase":"NA","title":"Ramipril for the Treatment of Oligospermia","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2013-07","conditions":"Oligospermia, Teratospermia, Asthenozoospermia","enrollment":2},{"nctId":"NCT01504828","phase":"NA","title":"Cardiac Energetics and Function in Normal Human Ageing","status":"COMPLETED","sponsor":"Newcastle-upon-Tyne Hospitals NHS Trust","startDate":"2012-07","conditions":"Left Ventricular Function Systolic Dysfunction, Left Ventricular Function Diastolic Dysfunction, Ageing","enrollment":135},{"nctId":"NCT02525081","phase":"PHASE4","title":"Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2015-07","conditions":"Microvascular Angina","enrollment":63},{"nctId":"NCT00939588","phase":"PHASE2","title":"Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-07","conditions":"Hypertension","enrollment":88},{"nctId":"NCT00878969","phase":"PHASE3","title":"Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3","status":"TERMINATED","sponsor":"Vanderbilt University","startDate":"2010-01","conditions":"Oxidative Stress, Endothelial Dysfunction","enrollment":78},{"nctId":"NCT00819845","phase":"PHASE4","title":"Ramipril Versus Carvedilol in Duchenne and Becker Patients","status":"UNKNOWN","sponsor":"Catholic University, Italy","startDate":"2008-12","conditions":"Duchenne Muscular Dystrophy, Becker Muscular Dystrophy","enrollment":194},{"nctId":"NCT00736294","phase":"PHASE3","title":"Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2008-07","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":198},{"nctId":"NCT00729365","phase":"PHASE3","title":"PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-07","conditions":"Type 1 Diabetes","enrollment":65},{"nctId":"NCT00750308","phase":"NA","title":"Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2006-12","conditions":"Metabolic Syndrome","enrollment":27},{"nctId":"NCT00153101","phase":"PHASE4","title":"Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2001-11","conditions":"Cardiovascular Diseases","enrollment":31546},{"nctId":"NCT01432106","phase":"PHASE1","title":"The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome","status":"WITHDRAWN","sponsor":"University of Michigan","startDate":"2011-02","conditions":"Hypertension, Metabolic Syndrome","enrollment":""},{"nctId":"NCT00732069","phase":"PHASE2","title":"Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2008-08","conditions":"End Stage Renal Failure on Dialysis, Complication of Hemodialysis","enrollment":19},{"nctId":"NCT00141778","phase":"PHASE2, PHASE3","title":"Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2005-04","conditions":"Atrial Fibrillation","enrollment":455},{"nctId":"NCT00325806","phase":"PHASE4","title":"Ramipril - Hypertension","status":"COMPLETED","sponsor":"Sanofi","startDate":"2000-05","conditions":"Hypertension","enrollment":1008},{"nctId":"NCT01052272","phase":"PHASE2, PHASE3","title":"Impact of Diabetes on Left Ventricular Remodeling","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2005-07","conditions":"Diabetes","enrollment":72},{"nctId":"NCT00355589","phase":"PHASE3","title":"Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-07","conditions":"Hypertension, Blood Pressure, High","enrollment":""},{"nctId":"NCT00044265","phase":"PHASE4","title":"Treatment of Pediatric Hypertension With Altace Trial","status":"COMPLETED","sponsor":"Pfizer","startDate":"2002-07","conditions":"Hypertension","enrollment":310},{"nctId":"NCT00292162","phase":"NA","title":"Curing Atrial Fibrillation in Heart Failure","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2007-01","conditions":"Chronic Heart Failure, Atrial Fibrillation","enrollment":41},{"nctId":"NCT00681226","phase":"PHASE4","title":"Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease","status":"COMPLETED","sponsor":"Bayside Health","startDate":"2008-01","conditions":"Peripheral Arterial Disease","enrollment":200},{"nctId":"NCT00437463","phase":"PHASE3","title":"Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-07","conditions":"Glomerulonephritis","enrollment":60},{"nctId":"NCT01225445","phase":"PHASE3","title":"Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2002-04","conditions":"Biopsy-confirmed IgA Nephropathy, Proteinuria Less Than 0.5 g Per Day, Normal Blood Pressure","enrollment":60},{"nctId":"NCT00443794","phase":"NA","title":"The Indian POLYCAP Study (TIPS)","status":"COMPLETED","sponsor":"St. John's Research Institute","startDate":"2007-03","conditions":"Cardiovascular Diseases","enrollment":2050},{"nctId":"NCT00221845","phase":"PHASE3","title":"Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"1998-01","conditions":"Children, Chronic Renal Failure, Hypertension","enrollment":400},{"nctId":"NCT00200694","phase":"PHASE4","title":"Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.","status":"TERMINATED","sponsor":"Nantes University Hospital","startDate":"2005-03","conditions":"Heavy Proteinuria","enrollment":18},{"nctId":"NCT00738660","phase":"PHASE3","title":"Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2007-02","conditions":"Diabetic Nephropathy","enrollment":30},{"nctId":"NCT00005928","phase":"PHASE2","title":"Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2000-06","conditions":"Atherosclerosis, Coronary Disease, Vasculitis","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":678,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ramipril"],"phase":"marketed","status":"active","brandName":"Ramipril (ACE-inhibitor)","genericName":"Ramipril (ACE-inhibitor)","companyName":"National Heart Institute, Egypt","companyId":"national-heart-institute-egypt","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ramipril inhibits angiotensin-converting enzyme (ACE), reducing the conversion of angiotensin I to angiotensin II and thereby lowering blood pressure and reducing cardiac workload. Used for Hypertension, Heart failure, Post-myocardial infarction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}